missing translation for 'onlineSavingsMsg'
Learn More
Learn More
ABCA1 Antibody, Janelia Fluor™ 646, Novus Biologicals™
Rabbit Polyclonal Antibody
Brand: Novus Biologicals NB400-105JF646
This item is not returnable.
View return policy
Description
ABCA1 Polyclonal antibody specifically detects ABCA1 in Human, Mouse, Rat, Porcine, Canine, Chicken, Chinese Hamster, Equine, Hamster, Mustelid, Primate, Rabbit samples. It is validated for Western Blot, Simple Western, ChIP assay, Flow Cytometry, ELISA, Immunohistochemistry, Immunocytochemistry/ Immunofluorescence, Immunoprecipitation, Immunohistochemistry (Paraffin), Immunohistochemistry (Frozen), Immunoblot, Gel Super Shift Assays, Gel Supershift Assay, ChIP assay (ChIP), Gene Knock-Out, KnockDown, Neutralization, PCR, Dual RNAscope ISH-IHC
Specifications
| ABCA1 | |
| Polyclonal | |
| 50mM Sodium Borate | |
| Rabbit | |
| Immunogen affinity purified | |
| RUO | |
| Primary | |
| Human, Mouse, Rat, Pig, Canine | |
| Purified |
| Western Blot, Simple Western, ChIP Assay, Flow Cytometry, ELISA | |
| Janelia Fluor 646 | |
| ABC-1, ABC1ATP-binding cassette transporter A1, ATP-binding cassette 1, ATP-binding cassette transporter 1, ATP-binding cassette, sub-family A (ABC1), member 1, CERP, Cholesterol efflux regulatory protein, EC 2.7.7.8, EC 2.8.1.8, EC 3.6.3, EC 3.6.3.41, FLJ14958, HDLDT1, membrane-bound, MGC164864, MGC165011, TGDATP-binding cassette sub-family A member 1 | |
| Partial peptide sequence (within residues 1100-1300) of human ABCA1 Antibody [UniProt# O95477]. Actual immunogen sequence is proprietary information. | |
| 0.1 mL | |
| ABC Transporters, Astrocyte Markers, Cancer, Cardiovascular Biology, Cellular Markers, Cholesterol Metabolism, Diabetes Research, Glia Markers, Golgi Apparatus Markers, Lipid and Metabolism, Neuroscience, Signal Transduction | |
| 19 | |
| Store at 4°C in the dark. | |
| IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction